finally an acquisition, page-9

This acquisition is exactly right for this shell company now, and despite the share dilution, over the next few months the stock should be active and rising.

This deal brings the one thing that Metabolic always lacked - cash flow.

PolyNovo has three partnering deals with credible global companies with milestone payments and potential royalties. The details of these deals are presently confidential, but as this acquisition is taken to completion, at least the rough outlines of these deals, and the potential cash flow MUST be made public.

Based on some educated wild guesses, my target six month price is 10 to 20 cents. I know that's a pretty wide target, but there isn't information available to me to let me refine the forecast. In two to three years, the shares could be substantially higher than that, depending on cash flow and profitability.

I will be aggressively adding to my holding of these shares.